Earnings Call Intelligence Subscribe
Home › Call Sheets › EMR › Q1'26
Call sheet · Q1'26

Emerson Electric (EMR)

Q1'26 earnings call · held February 3, 2026 · compared with the Q4'25 call · management-credibility review
10/12
Disclosure score
3 medium, 3 low flags
Financial quality
Bottom line
The sleeper story is Test & Measurement's broad-based portfolio recovery driving mix improvements that could add 50+ bps to margins, but everyone's focused on the power generation headlines. Yes, Ovation orders up 74% is impressive, but the real constraint isn't demand - it's DRAM supply chains stretching across their $8M exposure. Most concerning: they've quietly downgraded from 'monetizing billions of AI queries' to 'testing monetization,' while ACV growth missed their 10% target at just 9%. As Karsanbhai said, 'We're testing ads below the AI response' - that's not monetization, that's still figuring it out. My view changes if they can quantify Nigel AI conversion rates and sustain T&M momentum without DRAM bottlenecks gating the second-half acceleration.

The 30-second version

  • SLEEPER: T&M orders explosion is powering a stealth margin recovery that nobody sees coming
  • Power generation boom is real, but the constraint is DRAM availability not demand
  • Software ACV growth decelerated to 9% from 10% target while they pivot from 'monetization' to 'testing'

What changed this quarter

MetricQ4'25Q1'26Change
Underlying Sales Growth4% (Q4 2025)2% (Q1 2026)Decelerated 200bps
Adjusted Segment EBITDA Margin27.5% (Q4 2025)27.7% (Q1 2026)Up 20bps sequentially
Underlying Orders Growth6% (Q4 2025)9% (Q1 2026)Accelerated 300bps
Test & Measurement Orders27% (Q4 2025)20% (Q1 2026)Still robust but moderating
Software and Systems Underlying Sales5% growth (FY 2025)3% (Q1 2026)Decelerated 200bps
Ovation Business Orders30% (FY 2025)74% (Q1 2026)Massive acceleration
North America OrdersMid-single digits (Q4 2025 implied)18% (Q1 2026)Explosive acceleration
China OrdersSoft (Q4 2025)Down high single digits (Q1 2026)Deteriorating further
Free Cash Flow$3.24B (FY 2025)$202M (Q1 2026)14% margin vs 18% FY target
Backlog$7.4B (Q4 2025)$7.9B (Q1 2026)Up 9% YoY, 7% sequential

Accountability tracked

8 new promises made4 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full EMR Q1'26 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.